Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-009403
Filing Date
2017-05-08
Accepted
2017-05-08 16:19:24
Documents
45
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ttph-10q_20170331.htm 10-Q 1270158
2 EX-31.1 ttph-ex311_8.htm EX-31.1 17272
3 EX-31.2 ttph-ex312_7.htm EX-31.2 17530
4 EX-32.1 ttph-ex321_6.htm EX-32.1 6196
5 EX-32.2 ttph-ex322_9.htm EX-32.2 6223
  Complete submission text file 0001564590-17-009403.txt   3528727

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ttph-20170331.xml EX-101.INS 565074
7 XBRL TAXONOMY EXTENSION SCHEMA ttph-20170331.xsd EX-101.SCH 28727
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttph-20170331_cal.xml EX-101.CAL 24190
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttph-20170331_def.xml EX-101.DEF 82694
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttph-20170331_lab.xml EX-101.LAB 228026
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttph-20170331_pre.xml EX-101.PRE 167347
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Filer) CIK: 0001373707 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35837 | Film No.: 17822476
SIC: 2834 Pharmaceutical Preparations